Charles River Laboratories reported strong second-quarter results, with revenue of $914.6 million, a 34.0% increase year-over-year. GAAP earnings per share were $1.72, and non-GAAP earnings per share were $2.61. The company also increased its 2021 financial guidance due to sustained demand.
Second-quarter revenue was $914.6 million.
Second-quarter GAAP earnings per share were $1.72.
Second-quarter non-GAAP earnings per share were $2.61.
The company increased its 2021 financial guidance.
The Company is increasing its 2021 financial guidance, which was previously provided on May 4, 2021, primarily as a result of the stronger-than-expected second-quarter financial performance and an expectation that robust client demand trends will continue for the remainder of the year.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance